Scientists have developed a urine test that can detect pancreatic ductal adenocarcinoma (PDAC) up to 2 years before diagnosis.
PDAC remains one of the most lethal cancers, with median survival of 10-12 months and a 5-year survival rate of less than 5%. This poor prognosis is mainly attributed to late diagnosis....
